1.41
price up icon7.63%   0.10
after-market Dopo l'orario di chiusura: 1.48 0.07 +4.96%
loading
Precedente Chiudi:
$1.31
Aprire:
$1.36
Volume 24 ore:
698.81K
Relative Volume:
2.20
Capitalizzazione di mercato:
$68.11M
Reddito:
-
Utile/perdita netta:
$-90.97M
Rapporto P/E:
-0.7485
EPS:
-1.8837
Flusso di cassa netto:
$-32.83M
1 W Prestazione:
+17.50%
1M Prestazione:
-12.42%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$1.36
$1.53
Intervallo di 1 settimana:
Value
$1.19
$1.53
Portata 52W:
Value
$1.16
$2.0901

Filana Therapeutics Inc Stock (FLNA) Company Profile

Name
Nome
Filana Therapeutics Inc
Name
Telefono
512-501-2444
Name
Indirizzo
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN
Name
Dipendente
20
Name
Cinguettio
Name
Prossima data di guadagno
2026-05-14
Name
Ultimi documenti SEC
Name
FLNA's Discussions on Twitter

Compare FLNA vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
FLNA icon
FLNA
Filana Therapeutics Inc
1.41 63.28M 0 -90.97M -32.83M -1.8837
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-26 Downgrade H.C. Wainwright Buy → Neutral
2024-10-08 Aggiornamento H.C. Wainwright Neutral → Buy
2024-07-01 Downgrade H.C. Wainwright Buy → Neutral
2022-11-16 Downgrade B. Riley Securities Buy → Neutral
2021-07-15 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-07-07 Reiterato Maxim Group Buy
2021-04-27 Iniziato B. Riley Securities Buy
2021-02-16 Reiterato H.C. Wainwright Buy
2020-10-23 Iniziato Cantor Fitzgerald Overweight
2020-09-23 Aggiornamento H.C. Wainwright Neutral → Buy
2020-05-18 Downgrade H.C. Wainwright Buy → Neutral
2020-05-15 Downgrade Maxim Group Buy → Hold
2020-01-10 Reiterato Maxim Group Buy
Mostra tutto

Filana Therapeutics Inc Borsa (FLNA) Ultime notizie

pulisher
May 23, 2026

Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser

May 23, 2026
pulisher
May 23, 2026

FLNA Should I Buy - Intellectia AI

May 23, 2026
pulisher
May 21, 2026

Filana Therapeutics (FLNA) Stock: Up +0.80%, Key Resistance at $1.32 2026-05-21Community Trade Ideas - Newser

May 21, 2026
pulisher
May 21, 2026

FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

May 21, 2026
pulisher
May 21, 2026

FLNA Stock Price, Quote & Chart | FILANA THERAPEUTICS INC (NASDAQ:FLNA) - ChartMill

May 21, 2026
pulisher
May 12, 2026

MSN Money - MSN

May 12, 2026
pulisher
May 07, 2026

Filana Therapeutics 1Q Loss/Shr 21c >FLNA - Moomoo

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics (NASDAQ: FLNA) trims Q1 2026 loss, pivots simufilam to TSC epilepsy - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics Releases Q1 2026 Financial Results and Business Update on May 7, 2026 - geneonline.com

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - The Manila Times

May 07, 2026
pulisher
May 07, 2026

Cost cuts shrink Filana Therapeutics (NASDAQ: FLNA) Q1 2026 net loss - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Biotech with $86.6M cash says FDA hold keeps epilepsy trial on hold - Stock Titan

May 07, 2026
pulisher
May 05, 2026

Cassava Sciences | 8-K: Current report - Moomoo

May 05, 2026
pulisher
May 05, 2026

At a Madrid epilepsy meeting, Filana detailed why it’s testing simufilam - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewswire

May 05, 2026
pulisher
May 05, 2026

MSN - MSN

May 05, 2026
pulisher
Apr 28, 2026

[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan

Apr 28, 2026
pulisher
Apr 27, 2026

How does Filana Therapeutics (FLNA) make money? (Market Focus) 2026-04-27Senior Analyst Forecasts - newser.com

Apr 27, 2026
pulisher
Apr 24, 2026

Cassava Sciences (FLNA) Stock Price, News & Analysis $FLNA - MarketBeat

Apr 24, 2026
pulisher
Apr 21, 2026

FLNA Filana Therapeutics posts narrower than expected Q3 2025 loss, shares edge higher in today’s trading.Trade Idea Marketplace - Newser

Apr 21, 2026
pulisher
Apr 21, 2026

Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành

Apr 21, 2026

Filana Therapeutics Inc Azioni (FLNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Capitalizzazione:     |  Volume (24 ore):